TY - JOUR
T1 - Permeability characteristics of hemoglobin derivatives across cultured endothelial cell monolayers
AU - Nakai, Kunihiko
AU - Sakuma, Ichiro
AU - Ohta, Toshio
AU - Ando, Joji
AU - Kitabatake, Akira
AU - Nakazato, Yoshikazu
AU - Takahashi, Tsuneo A.
N1 - Funding Information:
From the Department of Cell Processing, Institute of Medical Science, Universityo f Tokyo; the Department of CardiovascularM edi-cine, Hokkaido University School of Medicine, Sapporo; the Laboratory of Pharmacology, Graduate School of Veterinary Medicine, Hokkaido University,S apporo; and the Department of Cardiovascular Biomechanics,F aculty of Medicine, Universityo f Tokyo. Supported in part by Research Grant 09557125 from the Ministry of Education, Science, and Culture and by the Ministry of Health and Welfare of Japan. Submitted for publication January 9, 1998; revision submitted June 1, 1998; accepted June 11, 1998. Reprint requests: K. Nakai, VMD, PhD, EnvironmentalH ealth Sciences, Tohoku UniversityG raduate School of Medicine, Sendal 980-8575, Japan. Copyright © 1998 by Mosby, Inc. 0022-2143/98 $5.00 + 0 5/1/92359 H emoglobin has been studied as an artificial oxygen carrier to substitute for red cell transfusion, but unmodified Hb has drawbacks in that it requires molecular modifications to decrease oxygen affinity and to prolong circulatory TI/2. These modifications include intramolecular and intermolecular cross-linking, conjugation to an inert material such as PEG, polymerization, and encapsulation into liposomes. Clinical trials with some acellular Hb derivatives were started recently. 1 In animal studies, facilitation of oxygen transport was demonstrated. 2 There have been few acute and chronic undesired effects after the infusion of acellular Hb derivatives, except that some preparations of acellular Hb derivatives have caused hypertension 2-5 and vasoconstriction 6-9 in animals.
PY - 1998/10
Y1 - 1998/10
N2 - To better understand the vascular activity of hemoglobin-based (Hb-based) oxygen carriers, the endothelial permeability characteristics of Hb derivatives having various molecular masses were defined by using monolayers of bovine endothelial cells cultured on microporous membranes. The endothelial permeability of unmodified bovine Hb was almost twice that of bovine serum albumin. Intramolecularly cross-linked human Hb showed slightly but significantly reduced permeability as compared with unmodified bovine Hb. Polyethyleneglycol modification or haptoglobin binding to Hb further reduced the permeability. These properties were intensified in conditions in which the endothelial barrier function was reduced by pretreatment with either interleukin-6 (100 ng/mL, 21 hours) or lipopolysaccharide (1 μg/mL, 10 hours). In contrast, there was little permeability of liposome-encapsulated Hb, and it was almost unaffected by the pretreatments. These data provide the first information that Hb derivatives with smaller molecular masses show larger transendothelial flux. Because Hb is a potent scavenger of endothelium-derived relaxing factor (EDRF), our observations support the idea that smaller Hb-based acellular oxygen carriers are potent vasoconstrictors as a result of abluminal EDRF scavenging.
AB - To better understand the vascular activity of hemoglobin-based (Hb-based) oxygen carriers, the endothelial permeability characteristics of Hb derivatives having various molecular masses were defined by using monolayers of bovine endothelial cells cultured on microporous membranes. The endothelial permeability of unmodified bovine Hb was almost twice that of bovine serum albumin. Intramolecularly cross-linked human Hb showed slightly but significantly reduced permeability as compared with unmodified bovine Hb. Polyethyleneglycol modification or haptoglobin binding to Hb further reduced the permeability. These properties were intensified in conditions in which the endothelial barrier function was reduced by pretreatment with either interleukin-6 (100 ng/mL, 21 hours) or lipopolysaccharide (1 μg/mL, 10 hours). In contrast, there was little permeability of liposome-encapsulated Hb, and it was almost unaffected by the pretreatments. These data provide the first information that Hb derivatives with smaller molecular masses show larger transendothelial flux. Because Hb is a potent scavenger of endothelium-derived relaxing factor (EDRF), our observations support the idea that smaller Hb-based acellular oxygen carriers are potent vasoconstrictors as a result of abluminal EDRF scavenging.
UR - http://www.scopus.com/inward/record.url?scp=0032192006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032192006&partnerID=8YFLogxK
U2 - 10.1016/S0022-2143(98)90045-2
DO - 10.1016/S0022-2143(98)90045-2
M3 - Article
C2 - 9794703
AN - SCOPUS:0032192006
SN - 1931-5244
VL - 132
SP - 313
EP - 319
JO - Translational Research
JF - Translational Research
IS - 4
ER -